INTC
Intel Corporation
INTC has the edge over MRAM overall, supported by stronger fundamentals and lower modeled downside.
MRAM
Everspin Technologies, Inc.
MRAM offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
MRAM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
MRAM's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
MRAM PE Valuation
MRAM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 105x next year's earnings.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
MRAM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect MRAM to return to profit, with revenue growing. However, they disagree widely on these estimates.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
MRAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.12 | — |
| Q3 2026 | -$0.40 | -$0.39 |
MRAM has the edge over INTC in the latest year-over-year earnings comparison.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over MRAM on profitability, with a higher operating margin.
MRAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.6M | +47% |
| Q2 2026 | $18.7M | +42% |
| Q1 2026 | $14.9M | +13% |
| Q4 2025 | $14.8M | +12% |
MRAM has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -23% | -8.5 points |
| Q1 2026 | -18% | -3.6 points |
| Q4 2025 | -7.2% | +4.5 points |
| Q3 2025 | -11% | N/A |
| Q2 2025 | -15% | N/A |
| Q1 2025 | -15% | N/A |
| Q4 2024 | -12% | N/A |
MRAM's operating margin was −23% last quarter, down 8.5 points from the same quarter a year ago, near the bottom of its range since 2024.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over MRAM in the latest year-over-year cash flow comparison.
MRAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2M | -138% |
| Q1 2026 | -$3.8M | -818% |
| Q4 2025 | -$975K | -147% |
INTC has the edge over MRAM in the latest year-over-year cash flow comparison.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
MRAM Net Leverage
MRAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
MRAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 19.9 | Oversold |
MRAM's weekly RSI is 44 (neutral) and its Stochastic is 20 (oversold).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
MRAM PE vs Technology Sector
| Metric | MRAM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
MRAM has no meaningful PE right now: it lost money over the past year.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 44% above its 200-week average.
MRAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.7 | 12% below |
| 20 week MA | $15.8 | 18% below |
| 50 week MA | $15.7 | 17% below |
| 100 week MA | $11.2 | 16% above |
| 200 week MA | $9.38 | 38% above |
MRAM has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 38% above its 200-week average.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over MRAM on returns for 2026, with the stronger performance.
MRAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.38 | $4.64 | -14% |
| 2021 | $4.64 | $11.1 | +139% |
| 2022 | $11.1 | $5.27 | -53% |
| 2023 | $5.27 | $9.04 | +72% |
| 2024 | $9.04 | $6.57 | -27% |
| 2025 | $6.57 | $9.38 | +43% |
| 2026 YTD | $9.38 | $12.9 | +38% |
MRAM's yearly returns have swung widely, from +139% in 2021 to −53% in 2022. It's up 38% so far in 2026.